Zobrazeno 1 - 10
of 379
pro vyhledávání: '"Robert G Robinson"'
Autor:
Aikaterini Vezyroglou, Suresh Pujar, Tricia Rutherford, Natasha E. Schoeler, Christin Eltze, Tom Barker, J. Helen Cross, Robert G. Robinson, Shamima Rahman, Hannah Smith, Zoe Simpson, Baheerathi Van de Bor, Simon Heales, Michael Orford, Robin S.B. Williams, Erika Brennan, Richard J. Jackson, Sanjeev Rajakulendran, Bridget Lambert, Umesh Vivekananda, Judith Kalser, Simon Eaton, Sophia Varadkar, Simona Balestrini, Sanjay M. Sisodiya, James McKenna, Matthew C. Walker
Publikováno v:
Brain Communications
This prospective open-label feasibility study aimed to evaluate acceptability, tolerability and compliance with dietary intervention with K.Vita, a medical food containing a unique ratio of decanoic acid to octanoic acid, in individuals with drug-res
Autor:
Robert G. Robinson, Kazunari Honma, Atsushi Mizuma, Kenji Yamamoto, Tsuyoshi Uesugi, Reina Kawamura, Yasushi Orihashi, Eiichiro Nagata, Katsunaka Mikami, Hideo Matsumoto, Shunya Takizawa, Keitaro Kimoto, Takeshi Sudo
Publikováno v:
The Journal of neuropsychiatry and clinical neurosciences. 33(1)
Despite the high frequency of depression in the first year following stroke, few studies have predicted risk of depression after the acute and subacute stroke periods. The aim of this study was to identify, in the acute and subacute periods, measures
Autor:
Robert G. Robinson
Publikováno v:
The American Journal of Geriatric Psychiatry. 25:1033-1039
Publikováno v:
The American Journal of Geriatric Psychiatry. 25:512-519
Objective This study re-examined patients from a 1-year randomized controlled double-blind trial of escitalopram, problem-solving therapy (PST), or placebo to prevent depression among patients less than 3 months after a stroke. The objective of the c
Autor:
Wendy A. Davis, Katherine K. Hatch, Robert G. Robinson, David G. Bruce, Simone Brockman, Osvaldo P. Almeida, Sergio E. Starkstein
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 25:1119-1127
Background To evaluate the efficacy of treatment with nefiracetam compared to placebo in poststroke apathy. Methods A parallel group, randomized, placebo-controlled, double-blind two-center trial in patients with recent stroke and apathy was conducte
Autor:
Robert G. Robinson, Ricardo E. Jorge
Publikováno v:
American Journal of Psychiatry. 173:221-231
Poststroke depression (PSD) has been recognized by psychiatrists for more than 100 years, but controlled systematic studies did not begin until the 1970s. Meta-analyses addressing almost all major clinical issues in the field have emerged because of
Autor:
Kevin M. Biglan, Ricardo E. Jorge, Jane S. Paulsen, Leigh J. Beglinger, Blair Olson, John N. Caviness, William Adams, Robert G. Robinson, Karl Kieburtz, Jess G. Fiedorowicz, Douglas R. Langbehn
Publikováno v:
Movement Disorders. 29:401-405
Background The objective of this study was to evaluate citalopram for executive functioning in Huntington's disease (HD). Methods The study was randomized, double-blind, and placebo-controlled. Thirty-three adults with HD, cognitive complaints, and n
Autor:
Robert G. Robinson
Publikováno v:
The American Journal of Geriatric Psychiatry. 21:817-820
Autor:
Steven L. Small, Stephan Arndt, Pasquale Fonzetti, Mijin Jang, Robert G. Robinson, Ana Solodkin, Katsunaka Mikami, David J. Moser, Mark T. Hegel, Ricardo E. Jorge
Publikováno v:
The American Journal of Geriatric Psychiatry. 21:855-862
Objective Apathy occurs frequently following stroke and prior studies have demonstrated the negative effect of apathy on recovery from stroke. This study was a secondary analysis examining the efficacy of escitalopram, problem-solving therapy (PST),
Autor:
Francesca Salani, Claudia Cacciari, Maurizia Rasura, Francesca Imperiale, Paola Bossù, Luca Cravello, Livio Picchetto, Marina Cao, Robert G. Robinson, Gianfranco Spalletta, Francesco Orzi, Floriana Pazzelli, Carlo Caltagirone
Publikováno v:
ResearcherID
The role of interleukin-6 (IL-6) as a risk factor for developing depressive symptoms, neuropsychological impairment, and related functional and neurological symptom severity during the acute phase of ischemic stroke is still underexplored. Here, the